Su1276 αE Integrin Expression As a Predictive Biomarker for Induction of Clinical Remission by Etrolizumab: Analysis of a Phase II Trial in Moderate-to-Severely Active Ulcerative Colitis

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 146; no. 5; p. S-422
Main Authors Keir, Mary E, Tew, Gaik Wei, Luca, Diana, Eastham-Anderson, Jeffrey, Diehl, Lauri, Egen, Jackson G, Vermeire, Severine, Mansfield, John C, Lamb, Christopher A, Feagan, Brian G, Panes, Julian, Baumgart, Daniel C, Schreiber, Stefan, Dotan, Iris, Sandborn, William, De Hertogh, Gert, Kirby, John A, Van Assche, Gert A, Rutgeerts, Paul J, O'Byrne, Sharon
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.05.2014
Subjects
Online AccessGet full text

Cover

Loading…
Author Vermeire, Severine
Dotan, Iris
Rutgeerts, Paul J
Luca, Diana
Tew, Gaik Wei
Kirby, John A
Van Assche, Gert A
Eastham-Anderson, Jeffrey
Feagan, Brian G
Diehl, Lauri
Sandborn, William
Mansfield, John C
Schreiber, Stefan
Panes, Julian
De Hertogh, Gert
O'Byrne, Sharon
Keir, Mary E
Baumgart, Daniel C
Egen, Jackson G
Lamb, Christopher A
Author_xml – sequence: 1
  fullname: Keir, Mary E
– sequence: 2
  fullname: Tew, Gaik Wei
– sequence: 3
  fullname: Luca, Diana
– sequence: 4
  fullname: Eastham-Anderson, Jeffrey
– sequence: 5
  fullname: Diehl, Lauri
– sequence: 6
  fullname: Egen, Jackson G
– sequence: 7
  fullname: Vermeire, Severine
– sequence: 8
  fullname: Mansfield, John C
– sequence: 9
  fullname: Lamb, Christopher A
– sequence: 10
  fullname: Feagan, Brian G
– sequence: 11
  fullname: Panes, Julian
– sequence: 12
  fullname: Baumgart, Daniel C
– sequence: 13
  fullname: Schreiber, Stefan
– sequence: 14
  fullname: Dotan, Iris
– sequence: 15
  fullname: Sandborn, William
– sequence: 16
  fullname: De Hertogh, Gert
– sequence: 17
  fullname: Kirby, John A
– sequence: 18
  fullname: Van Assche, Gert A
– sequence: 19
  fullname: Rutgeerts, Paul J
– sequence: 20
  fullname: O'Byrne, Sharon
BookMark eNqFkcFu3CAQhlGUSt2kfYRKHNuDG8CGmB5abVebdKVUibrJGWEYUhKvicC7qvtWOecd8kzF66iHXnqBETP_N-j_j9BhFzpA6B0lHymh4mRN8llwUvP3tPogKGes4Adolou6yD12iGZ_R16jo5TuCCGyrOkMPa23lJ0K_Py4xKuuh9voO7z89RAhJR86PE9Y46sI1pve7wB_9WGj4z1E7ELMCrvN73kuOLxofeeNbvEP2PhJ3Qx42cfQ-t_bjW4-4Xmn2yH5NI5n7E-dAK9W-Dr6LMuLvwcLUfdQ9KFYww4itAOeT5tvWjP2xnKRib1Pb9Arp9sEb1_uY3RztrxefCsuLs9Xi_lFYRgXvJDScd5I42ppuC6dpJYRYZmw4IS0sj41orGscaWttCC2IrTWFTjJKqG1qcpjxCeuiSGlCE49RJ9dGBQlakxA7RNQo72KVmqfgOJZ92XSQf7czkNUyXjoTDYzgumVDf6_hM__EMyLyfcwQLoL25gdTYqqxBSZICODVnsCL_8AlkmnaQ
CitedBy_id crossref_primary_10_1016_j_clim_2015_04_006
ContentType Journal Article
Copyright AGA Institute
2014 AGA Institute
Copyright_xml – notice: AGA Institute
– notice: 2014 AGA Institute
DBID AAYXX
CITATION
DOI 10.1016/S0016-5085(14)61522-5
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1528-0012
EndPage S-422
ExternalDocumentID 10_1016_S0016_5085_14_61522_5
S0016508514615225
1_s2_0_S0016508514615225
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
1B1
1CY
1P~
1~5
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
AAEDT
AAEDW
AAIKJ
AALRI
AAQFI
AAQOH
AAQQT
AAQXK
AAXUO
AAYOK
ABCQX
ABJNI
ABLJU
ABMAC
ABOCM
ADBBV
ADMUD
ADPAM
AENEX
AEVXI
AFCTW
AFFNX
AFHKK
AFJKZ
AFRHN
AFTJW
AGHFR
AI.
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
BR6
C5W
CAG
COF
CS3
DU5
EBS
EFJIC
EJD
F5P
FD8
FDB
FEDTE
FGOYB
G8K
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N4W
N9A
NQ-
O9-
OC.
OHT
ON0
P2P
PC.
QTD
R2-
RIG
ROL
RPZ
SEL
SES
SJN
SSZ
TWZ
UDS
UGJ
UV1
VH1
WH7
X7M
XH2
Y6R
YQJ
Z5R
ZGI
ZXP
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
ID FETCH-LOGICAL-c2565-99f55b9cf89c5a3f91d206d26def69d987c6bd2bf3d4a60d4018a4ef9246aac43
ISSN 0016-5085
IngestDate Thu Sep 26 15:20:44 EDT 2024
Fri Feb 23 02:23:29 EST 2024
Tue Oct 15 14:34:08 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2565-99f55b9cf89c5a3f91d206d26def69d987c6bd2bf3d4a60d4018a4ef9246aac43
OpenAccessLink https://doi.org/10.1016/s0016-5085(14)61522-5
ParticipantIDs crossref_primary_10_1016_S0016_5085_14_61522_5
elsevier_sciencedirect_doi_10_1016_S0016_5085_14_61522_5
elsevier_clinicalkeyesjournals_1_s2_0_S0016508514615225
PublicationCentury 2000
PublicationDate May 2014
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: May 2014
PublicationDecade 2010
PublicationTitle Gastroenterology (New York, N.Y. 1943)
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0009381
Score 2.1540956
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S-422
SubjectTerms Gastroenterology and Hepatology
Title Su1276 αE Integrin Expression As a Predictive Biomarker for Induction of Clinical Remission by Etrolizumab: Analysis of a Phase II Trial in Moderate-to-Severely Active Ulcerative Colitis
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0016508514615225
https://dx.doi.org/10.1016/S0016-5085(14)61522-5
Volume 146
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELb2ISEuiKcoC8gHVgJFLnk4ac2tW4VuWZYDbWFvkeM4uxHbFDXtofuvOPMf-E2MY-cBWxDsxWojP5LMl5nxeB4IvQARJ1MW-MRP44RQmlDCPCFJIDhLOU_juDTon34Ijmf03Zl_trN70PJaWq_irrjaGldyE6rCNaCripL9D8rWk8IF-A30hRYoDO0_0XiydtxeYB0Ow8MjJyyte-fLLFf5i7V7aw6v3-LKzyLJSsamak_OlUfOsvQvVIU7RKUzDqsgyY-qBlw5GnTTUHmyZ1frOY-1EbFJYgITX4AQtMZja6qLf-S6thror2S1IBMJb1RebqyBXnt2KaRJND4s3e6Ktmo84gUspVKELnVeqC11giyH0bZp-ERmSxNxtGliKqayPK8a8eyL9Vlmtc_RWujDLfgiamEUwqoXfE4GZZCPdkEw0W1tg4hDG_fDisk7AQG90_-FyRtDZ9Y-Ry9Z9oRQHRlt5H_9_5pw0XaOST2_yqRF4ZlBKVQ7-kaiVl4E4fDEIYXbtUk5SI1RZdSh92-d9XYsKtzIjq513UX7LnBRYN_7o6P3nwZNTmmvrwtCmvtpAtReNzf50qGvzA1uV71a6tT0Lrpj9kF4oEF9D-3I_D66dWo8PR6g7xrb-Me3EFe4xg2u8aDAHDe4xjWuMeAa17jGixRXuMY1rnG8wS1cv8EVqlV3mFahGo_HuEQ1hoW3oRprVOMG1dig-iGavQ2nw2NiCo0QARq_TxhLfT9mIu0z4XMvZU7i2kHiBolMA5awfk8EceLGqZdQHtgJtZ0-p8DjXBpwLqj3CO3li1w-RthPPZ-nktmeZLTPfN4TNPCEcLzYhqtuB3UrGkRfdT6ZqHG0VK0iGmzIo5Jokd9BvYpSURUsDeJdFoYPFdGfcNNB_XqkUae1mhwBoP--6JMbL3qAbjff5FO0t1qu5TNQ21fxcwPfn1fJ5f0
link.rule.ids 315,783,787,27936,27937
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Su1276+%CE%B1E+Integrin+Expression+As+a+Predictive+Biomarker+for+Induction+of+Clinical+Remission+by+Etrolizumab%3A+Analysis+of+a+Phase+II+Trial+in+Moderate-to-Severely+Active+Ulcerative+Colitis&rft.jtitle=Gastroenterology+%28New+York%2C+N.Y.+1943%29&rft.au=Keir%2C+Mary+E&rft.au=Tew%2C+Gaik+Wei&rft.au=Luca%2C+Diana&rft.au=Eastham-Anderson%2C+Jeffrey&rft.date=2014-05-01&rft.issn=0016-5085&rft.volume=146&rft.issue=5&rft.spage=S-422&rft.epage=S-422&rft_id=info:doi/10.1016%2FS0016-5085%2814%2961522-5&rft.externalDBID=ECK1-s2.0-S0016508514615225&rft.externalDocID=1_s2_0_S0016508514615225
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00165085%2FS0016508514X60014%2Fcov150h.gif